Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Subscribe
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Subscribe
FREE
Meet GOLD’s new catalyst – medical aficionado Juby Jacob-Nara
An exclusive version of our conversation Juby Jacob-Nara (Sanofi) about how former physicians can empower themselves to succeed in the pharmaceutical industry.
5 Sep 2022
Latest updates in Advanced Systemic Mastocytosis from EHA 2022
Latest updates in Advanced Systemic Mastocytosis from EHA 2022. Targeting systemic mastocytosis. Update in Haematology session EHA 2022, Prof. Olivier Hermine introduces the session on overcoming the challenges in diagnosis and management of advanced systemic macrocytosis.
5 Sep 2022
No Increased Risk of Breast Cancer Relapse Following Fertility Preservation
Individuals undergoing fertility preservation alongside chemotherapy are not at an increased risk of disease recurrence. Read more…
5 Sep 2022
Could Cell Transition Markers Aid Treatment of Pancreatic Cancer?
This research provides hope for the future in terms of identifying cells at the pre-cancerous stage to prevent progression to cancer…
6
Mins
5 Sep 2022
COVID-19 and Antimicrobial Resistance
For decades, infectious disease and public health experts have recognised antimicrobial resistance (AMR) and resulting infections due to multidrug resistant organisms as a persistent and increasingly urgent threat to public health at the local, national, and global level.
Driving post-conference motivation in pharma: a how-to guide
How can pharma embrace post-conference momentum?
11
Mins
2 Sep 2022
Gene Therapy in Haemophilia: Updates from Clinical Trials and Insights to Future Technologies
At the International Society on Thrombosis and Haemostasis (ISTH) 2022 Congress, held 9th–13th July, multiple oral and poster presentations were dedicated to gene therapy as a treatment for haemophilia A or B.
2 Sep 2022
Can Artificial Intelligence Aid in Personalised Epilepsy Management?
Researchers demonstrated the potential of an AI model to predict treatment success with the first antiseizure medication for epilepsy…
2 Sep 2022
The Neurologic Manifestations of Monkeypox
Based on animal models and previous case series, it is known that monkeypox has the potential to be neuroinvasive. Read for more details…
2 Sep 2022
Driving Dermatology Research
This week, Jonathan sits down with Robert Dellavalle, Professor of Dermatology, Colorado School of Medicine, Aurora, USA.
←
1
2
3
…
313
314
315
316
317
318
319
…
921
922
923
→